Robert Rydzewski, Ms, Cmpp Email & Phone Number

Providing timely, high-quality content development and publication planning assistance to ensure accurate, fully compliant, maximum impact medical communications for peer reviewed journals and congresses. My areas of expertise to date include solid tumor (e.g., NSCLC, RCC) and hematologic (e.g. CLL, DLBCL, FL, MCL, MM, PTCL) malignancies, with an emphasis on personalized/precision medicine, targeted therapies, and health-related quality of life (HRQoL). Other areas of expertise include fibrotic diseases (e.g. NASH), cardiopulmonary (e.g. PAH) and cardiovascular disease, and other indications. I've provided writing assistance for preclinical through phase IV studies.

Worked with thought leaders, clinicians, biostatisticians, and other team members to provide accurate, transparent high-impact journal articles and congress presentations (ASCO, ASH, EHA, ICML) on clinical trials of novel agents in hematologic malignancies. Assisted with primary manuscripts, secondary manuscripts, meta-analysis, and review articles. Also provided strategic and tactical publication planning assistance including gap analysis, scientific statement development, and advisory boards. Trained in Datavision software.

Medical writing and publication planning experience for small molecules and biologics used in solid tumors and hematologic malignancies. Developed CSR synopsis, multimedia medical education materials, investigator newsletters, and clinical trial outlooks.

Provided fully compliant writing assistance for journal articles and congress presentations.

Authored a book describing essential scientific, business, and legal aspects of pharma/biotech drug discovery that was published by Elsevier in 2008.

Project leader for early stage oncology research.

Us

Master Of Science (M.S.), Organic Chemistry

Education record